Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Transformation of Postoperative Adjuvant Therapy of Tumor Antigen-sensitized DC Vaccine Applied to Esophagus Cancer

NCT05023928 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT05023928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05023928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Transformation of Postoperative Adjuvant Therapy of Tumor Antigen-sensitized DC Vaccine Applied to Esophagus Cancer
Lead sponsor
Sichuan University
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2021
Completion date
October 30, 2024
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, esophagus cancer